Lumos Pharma Announces Participation in the Piper Sandler 35th Annual Healthcare Conference in November

AUSTIN, Texas, Nov. 20, 2023 -- Lumos Pharma, Inc. , a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, today announced that the Company will participate in the...

Related Keywords

New York ,United States ,Texas ,Piper Sandler ,Lumos Pharma ,Lisa Miller ,Lumos Pharma Inc ,Nasdaq ,Annual Healthcare Conference ,Lumos Pharma Investor Relations ,Pediatric Growth Hormone Deficiency ,Orphan Drug Designation ,Media Contact ,